Post by
txbioinv on Oct 24, 2015 2:15pm
Early Approval?
Upon a positive vote by the ADcom for recommendation of FDA approval; I believe TST will receive an early 'unexpected green light' BEFORE the February 2016 PDUFA date. The Sanofi plant that makes the toxic BCG therapy is due to be back online by EOY supposedly, even if so, they have do their pilot runs and etc to resume fulltime regular production. I am not sure where Merck stands currently on production(they too had production issue). So my fellow longs, be ready, everyday, after November 18th, because one never knows what the FDA will do, especially if the TST Adcom travel team includes a couple dying patients waiting on BCG and a doctor or two giving statements of how their administering the BCG drug at 1/3 qtys because of shortages. Be ready and GL longs
Comment by
simouuun on Oct 26, 2015 2:09pm
pls re-post. It is not readable.
Comment by
loveshackdave on Oct 26, 2015 3:23pm
Right, right, but they can't pitch this to the FDA as a reason to give MCNA a pass. They also can't advertise it to doctor's or insurance companies as a first line alternative until it is approved for first line by FDA. Of course doctors will prescribe it and insurance companies will probably pay for it unless it is a lot more expensive than BCG.
Comment by
txbioinv on Oct 26, 2015 3:52pm
Yes.....I agree completely
Comment by
DamnYankees on Oct 26, 2015 5:29pm
LSD, none of this matters until the next round of options/dilution and reverse takes place. No volume and no interest in Telesta Or Banhelef until Options and Reverse. Come back in late February after the 15 for 1 at 27 cents US. These are the most compelling near term milestones as interest and trading indicates